Form 4 for CRL Charles River Laboratories
Accepted 2022-11-17 00:00:00 ET · period of report 2022-11-16 · accession 0001127602-22-025979 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-17 | 2022-11-16 | CRL | Knell Michael Gunnar | CAO, CSVP | M - OptEx | $109.34 | +855 | 7,293 | +13% | +$93.5K |
| D | 2022-11-17 | 2022-11-16 | CRL | Knell Michael Gunnar | CAO, CSVP | S - Sale+OE | $248.59 | -855 | 6,438 | -12% | -$212.5K |
| D | 2022-11-17 | 2022-11-16 | CRL | Knell Michael Gunnar | CAO, CSVP | M - OptEx | $0.00 | -855 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-16 | M | A | 855 | $109.34 | 7,293 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-16 | S | D | 855 | $248.59 | 6,438 | D | — | — | |
| 3 | Derivative | Stock Options (Right to Buy) | 2022-11-16 | M | D | 855 | $0.00 | 0 | D | $109.34 · 2019-02-23 to 2023-02-23 | 855 Common Stock |